Puberty blocker JR stayed till July

James Esses (with beard on rthe ight) leaves court with his legal team

The government’s attempt to stay James Esses, Keira Bell and the Bayswater Group’s judicial review (JR) of the Pathways Puberty Blocker trial has succeeded. There will now be an eight week pause in proceedings to give the Medicines and Healthcare products Regulatory Agency (MHRA) and King’s College London (KCL) a chance to discuss the issues raised by Professor Jacob George before he was recused from involvement in the trial due to his social media posts.

The trial – which plans to give up to 300 pre-pubsescent children drugs to delay the onset of puberty and ask them how they think they’re getting on – was due to start around now. The JR aimed to stop the trial, citing all sorts of problems with the methodology behind it and the harm it might cause the participants. The trial was paused by the government when the MHRA’s Professor George wrote to KCL in February telling them that as there were “potentially significant and, as yet, unquantified risk of long-term biological harms” to taking these drugs and “there should be a graded/stepwise approach starting with those aged 14 as the lower limit of eligibility.”

There were also issues about preserving the fertility of pre-pubescent children.

Esses, Bell and the Bayswater Group (the claimants) did not want the JR paused. They felt the concerns raised by the MHRA aided their case – which is that the puberty blocker trial should not go ahead, based on the idea that putting powerful experimental drugs into children was likely to cause harm.

At the end of a two hour hearing the judge sided with the government, with two important caveats. First – there would be no recruitment of young people to the PB trial before the end of July. Second – the claimants would get what they need in terms of disclosure.

JR proceedings will now be stayed for eight weeks. In that eight weeks, the MHRA and KCL will decide what (if any) changes need to be made to the PB trial in the light of Professor George’s letter. If the MHRA and KCL cannot agree on what changes need to be made, the trial will collapse, and the JR becomes irrelevant. If the MHRA and KCL make agreed changes, those changes will be scrutinised by the JR at the High Court.

The timetable going forward (as proposed by Andrew Sharland, representing KCL) is as follows:

27 April – MHRA and KCL complete their discussions and issue the new PB trial protocol
27 April – JR re-starts – amended claim form prepared, along with statement of facts and further evidence
15 May – four hour hearing to to determine Claimants’ application to rely on expert evidence
6 July – JR hearing. This will be two days if expert evidence is ruled inadmissible or 3 to 4 days if expert evidence is allowed.
31 July (latest) – JR judgment. PB trial either begins recruiting, or stops.

The timetable was largely accepted by all parties, on the condition the defendants got the disclosure they wanted in good time. The government made it clear that whilst they would not start recruiting any children into the trial before the end of July, they reserved the right to do so from 1 August onwards. So – if the JR ruling is delayed, or the JR fails but goes to appeal, the government might let KCL begin recruiting children to the trial.

One matter of note which came out of the hearing related to the kids in the centre of this. The claimants believe the trial will cause harm, and the judge recognised that. King’s College London (and the government) want the matter resolved as soon as possible, so the trial can (if it is allowed) go ahead.

Andrew Sharland, KCL’s barrister, said the cohort of potential triallists is “fragile” and “some are self-medicating with puberty suppressants… there’s a high level of self-harm – attempted suicide.”

This was a striking assertion and one I have asked Mr Sharland to clarify. His statement suggests KCL is already in touch with a potential cohort of children (and parents?) desperate to start the trial, and that one of the reasons for urgency is that some of them are harming themselves and self-medicating with puberty blockers.

Is the desperation of some people to potentially self harm a reason for starting a trial? I don’t know. As someone close to the story told me, any child who has already taken puberty blockers is not allowed to take part in the trial. The desperation may therefore be real, but not necessarily relevant. If I get a response from Mr Sharland I will post it here. But it was a significant statement to make in open court.

Thanks to everyone who followed my live tweets yesterday and anyone reading this post. Please donate if you can.


My work on this blog is funded by your donation. If you would like to make a one-off contribution and receive the Gender Blog newsletter and blog posts in your email inbox you can sign up here. Your email address will be stored securely and confidentially, never given to a third party and will only be used to inform you about things I think are interesting. If you have a story, please use the contact form. All messages go directly and securely to my email inbox and will be dealt with in the utmost confidence.

Comments

8 responses to “Puberty blocker JR stayed till July”

  1. Thanks for this work you are doing, at least getting the 12 week plus period to explore the worth of this trial (not worthy in my clinical experience) was a good interim outcome.

  2. Pre-pubertal children self medicating? Would those negligent parents allow their children to self medicate with any other drug? Perhaps keeping them off social media and ensuring that they provide a safe, loving environment with firm boundaries would be a better idea. And if they are autistic and / or gay then the money allocated to this disgraceful trial could be spent on appropriate support for their differences.

  3. This was a striking assertion and one I have asked Mr Sharland to clarify. His statement suggests KCL is already in touch with a potential cohort of children (and parents?) desperate to start the trial, and that one of the reasons for urgency is that some of them are harming themselves and self-medicating with puberty blockers.

    Is the desperation of some people to potentially self harm a reason for starting a trial? I don’t know. As someone close to the story told me, any child who has already taken puberty blockers is not allowed to take part in the trial.

    Do I understand this correctly? The trial is urgently needed because some potential recruits are self-medicating with PBs but someone already taking PBs isn’t allowed on to the trial?

  4. I take it that nobody in court asked Sharland to clarify/justify that assertion. Was it remarked upon by other barristers?
    (And the big question is, where are all the (attempted) suicides that have taken place up until now?)

  5. Sharon Z avatar

    Thanks for this explanatory note on the proceedings Nick. It was quite a difficult read on Twitter but I picked up on the desperate children already accessing PBs illegally and thought it strange in the framework of this so called trial. I hope they get appropriate help.

  6. JezGrove avatar

    “one of the reasons for urgency is that some of them are harming themselves and self-medicating with puberty blockers”.

    If they are already accessing puberty blockers they must be ineligible for the trial, surely? Although given the mess surrounding it, perhaps not.

  7. David Lewis avatar
    David Lewis

    The trials should not be going ahead as no one under 18 (possibly 16, being the age of consent) should be taking medication such as is suggested.

    I also feel the government should not be proceeding on 1 August because a person ‘may’ self harm or take blockers.

    Medical trials should not occur on the basis of a potential future event. Medical trials should be to assess whether a medication works for a diagnosed illness.

  8. Catherine Pennington avatar
    Catherine Pennington

    The KCL team barrister’s comments about planning to recruit children who are currently using blackmarket puberty blockers are very concerning. The trial protocol states that previous or current exposure to puberty blockers is a research exclusion criteria. To recruit any children with past or current puberty blockers use is a breach of trial protocol. Protocol breaches are very serious and this should be investigated further. Recruiting someone who is already using the investigational medical product will clearly impact on the scientific validity of trial results and is therefore a serious breach.
    Please see the following for more information:

    https://assets.publishing.service.gov.uk/media/5f22f594e90e071a603d33f4/Guidance_for_the_Notification_of_Serious_Breaches_of_GCP_or_the_Trial_Protocol_Version_6__08_Jul_2020.pdf

    It is also inappropriate to be actively screening possible trial participants when the study is not open.

Leave a Reply to Alan Henness Cancel reply

Your email address will not be published. Required fields are marked *